TP53 and Dravet syndrome: The increased risk for childhood leukemia in DS could therefore be related early cellular mechanisms related to the cancer-promoting effects of high leptin levels from leptin resistance (anti-apoptosis mediated in part through down-regulation of p53), and decreased leukemia—suppressing (apoptotic) effects from lower childhood adiponectin levels.